These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 700914)

  • 1. Effect of antirheumatic drugs on proteinases in synovia of patients with rheumatoid arthritis.
    Haataja M; Fräki JE; Vainio E
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):417-9. PubMed ID: 700914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antirheumatic drugs on cathepsin B1 from bovine spleen.
    Kruze K; Fehr K; Böni A
    Z Rheumatol; 1976; 35(3-4):95-102. PubMed ID: 817531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S.
    Weidauer E; Yasuda Y; Biswal BK; Cherny M; James MN; Brömme D
    Biol Chem; 2007 Mar; 388(3):331-6. PubMed ID: 17338641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thiol-proteolytic activity in rheumatoid polyarthritis. Assay by spectrofluorimetry].
    Flipo RM; Héron F; Huet G; Balduyck M; Degand P; Duquesnoy B; Delcambre B
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):131-3. PubMed ID: 2042009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antirheumatic drugs on neutral protease from human leucocyte granules.
    Kruze D; Fehr K; Menninger H; Böni A
    Z Rheumatol; 1976; 35(9-10):337-46. PubMed ID: 136142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Rheumatol; 1988 Aug; 15(8):1198-204. PubMed ID: 3054093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dipeptidyl peptidase IV activity in the serum and synovia of patients with rheumatoid arthritis].
    Küllertz G; Boigk J
    Z Rheumatol; 1986; 45(2):52-6. PubMed ID: 2873694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochemical investigation of cathepsin B in rheumatoid synovial membrane and fluid.
    Codorean E; Gabrielescu E
    Morphol Embryol (Bucur); 1985; 31(4):269-74. PubMed ID: 2934623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of lysozyme in the blood, urine and synovial fluid in different stages of rheumatoid polyarthritis and under the influence of therapy].
    Georgesco C; Serban M; Gheorghiu M
    Med Interne; 1981; 19(1):51-4. PubMed ID: 7233047
    [No Abstract]   [Full Text] [Related]  

  • 10. [The status of various indicators of the protease inhibitor system in blood and synovial fluid in rheumatoid arthritis].
    Danilova TG; Platonova LV; Paskhina TS
    Vopr Med Khim; 1993; 39(3):40-3. PubMed ID: 8101408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A remarkable increase of superoxide dismutase activity in synovial fluid of patients with rheumatoid arthritis.
    Igari T; Kaneda H; Horiuchi S; Ono S
    Clin Orthop Relat Res; 1982; (162):282-7. PubMed ID: 7067225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antirheumatic enzyme therapy approach].
    Galmiche P; Neukirch G
    Rev Rhum Mal Osteoartic; 1972 Mar; 39(3):215-20. PubMed ID: 4653758
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the proteinase inhibitor alpha 2-macroglobulin in synovial fluids of arthritis of different origins and its relation to serologic parameters].
    Borth W; Menzel EJ; Kubin A; Dunky A; Heckl F
    Wien Klin Wochenschr; 1983 Dec; 95(24):873-7. PubMed ID: 6199906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The possibilities of an individual approach to intra-articular drug administration in rheumatoid arthritis patients].
    Matveĭkov GP; Soroka NF; Maksimovich AB
    Ter Arkh; 1989; 61(12):121-4. PubMed ID: 2629140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoelectrophoresis of inter-alpha-trypsin-inhibitor in the serum and synovial fluid of the patient with rheumatoid arthritis (author's transl)].
    Nishioka J; Shichikawa K; Ansell BM; Howard A
    Ryumachi; 1979 Aug; 19(4):346-52. PubMed ID: 317174
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteinase inhibitors in rheumatoid arthritis.
    Brackertz D; Hagmann J; Kueppers F
    Ann Rheum Dis; 1975 Jun; 34(3):225-30. PubMed ID: 1080403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of anti-inflammatory agents on the granulocyte enzymes elastase and cathepsin G].
    Steinmeyer J; Kalbhen DA
    Arzneimittelforschung; 1989 Oct; 39(10):1208-11. PubMed ID: 2610712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activities of plasma-membrane marker enzymes in rheumatoid synovial tissues and fluids.
    Takala I; Mäkisara P; Kulonen E
    Scand J Rheumatol; 1977; 6(1):33-6. PubMed ID: 139678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic enzymes in joint destruction.
    Peltonen L; Puranen J; Lehtinen K; Korhonen LK
    Scand J Rheumatol; 1981; 10(2):107-14. PubMed ID: 7017914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.